Pfizer Clinical Trials

Find clinical trials for Pfizer. Search for Pfizer clinical trials in different cities and states across the United States.

e.g. Respiratory Diseases

e.g. Massachusetts•Healthy volunteers: No

Filter results

Results: 66

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Dothan, Mobile, Peoria, Sun Cityshow 92 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Iowa City, New Hyde Park, Seattle

Code:

NCT05145127

Conditions

Hemophilia A

Hemophilia B

Eligibility Criteria

Sex: Male

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

PF-06741086

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Birmingham, Encinitas, Fremont, Huntington Beachshow 36 more

Code:

NCT05583526

Conditions

Stable Nonsegmental Vitiligo

Active Nonsegmental Vitiligo

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Ritlecitinib

Placebo

Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Phoenix, Los Angeles, San Francisco, Farmingtonshow 14 more

Code:

NCT04624230

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

tofacitinib

A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

Recruiting

Phase 1

Sponsor:

Pfizer

Location:

Fayetteville, Rogers, Springdale, Tampashow 6 more

Code:

NCT05538130

Conditions

Melanoma

Glioma

Thyroid Cancer

Non-Small Cell Lung Cancer

Malignant Neoplasms

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

PF-07799544

PF-07799933

encorafenib

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

Recruiting

Phase 2

Sponsor:

Pfizer

Location:

Gilbert, Little Rock, Beverly Hills, Los Angelesshow 18 more

Code:

NCT05090566

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elranatamab + Nirogacestat

Elranatamab + lenalidomide + dexamethasone

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Recruiting

Phase 1

Sponsor:

Pfizer

Location:

Fayetteville, Rogers, Springdale, Duarteshow 1 more

Code:

NCT06447662

Conditions

Carcinoma, Pancreatic Ductal

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07934040

Gemcitabine

Nab-paclitaxel

Cetuximab

Fluorouracil

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Recruiting

Phase 1

Sponsor:

Pfizer

Location:

Fayetteville, Rogers, Springdale, Aurorashow 11 more

Code:

NCT05355701

Conditions

Melanoma

Non-Small-Cell Lung Cancer

Thyroid Cancer

Glioma

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

PF-07799933

binimetinib

cetuximab

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Salt Lake City

Code:

NCT05611801

Conditions

Hemophilia A

Hemophilia B

Eligibility Criteria

Sex: Male

Age: 1 - 17

Healthy Volunteers: Not accepted

Interventions

marstacimab

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Recruiting

Sponsor:

Pfizer

Location:

Mesa, Valencia, Clearwater, Lutzshow 7 more

Code:

NCT06398626

Conditions

Colitis, Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Etrasimod

e.g. Respiratory Diseases

e.g. Massachusetts•Healthy volunteers: No

Filter results

Results: 66

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Dothan, Mobile, Peoria, Sun Cityshow 92 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Iowa City, New Hyde Park, Seattle

Code:

NCT05145127

Conditions

Hemophilia A

Hemophilia B

Eligibility Criteria

Sex: Male

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

PF-06741086

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Birmingham, Encinitas, Fremont, Huntington Beachshow 36 more

Code:

NCT05583526

Conditions

Stable Nonsegmental Vitiligo

Active Nonsegmental Vitiligo

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Ritlecitinib

Placebo

Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Phoenix, Los Angeles, San Francisco, Farmingtonshow 14 more

Code:

NCT04624230

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

tofacitinib

A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

Recruiting

Phase 1

Sponsor:

Pfizer

Location:

Fayetteville, Rogers, Springdale, Tampashow 6 more

Code:

NCT05538130

Conditions

Melanoma

Glioma

Thyroid Cancer

Non-Small Cell Lung Cancer

Malignant Neoplasms

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

PF-07799544

PF-07799933

encorafenib

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

Recruiting

Phase 2

Sponsor:

Pfizer

Location:

Gilbert, Little Rock, Beverly Hills, Los Angelesshow 18 more

Code:

NCT05090566

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elranatamab + Nirogacestat

Elranatamab + lenalidomide + dexamethasone

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Recruiting

Phase 1

Sponsor:

Pfizer

Location:

Fayetteville, Rogers, Springdale, Duarteshow 1 more

Code:

NCT06447662

Conditions

Carcinoma, Pancreatic Ductal

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07934040

Gemcitabine

Nab-paclitaxel

Cetuximab

Fluorouracil

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Recruiting

Phase 1

Sponsor:

Pfizer

Location:

Fayetteville, Rogers, Springdale, Aurorashow 11 more

Code:

NCT05355701

Conditions

Melanoma

Non-Small-Cell Lung Cancer

Thyroid Cancer

Glioma

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

PF-07799933

binimetinib

cetuximab

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Salt Lake City

Code:

NCT05611801

Conditions

Hemophilia A

Hemophilia B

Eligibility Criteria

Sex: Male

Age: 1 - 17

Healthy Volunteers: Not accepted

Interventions

marstacimab

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Recruiting

Sponsor:

Pfizer

Location:

Mesa, Valencia, Clearwater, Lutzshow 7 more

Code:

NCT06398626

Conditions

Colitis, Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Etrasimod